Companies are warning of a handful of consequential immigration enforcement risks beyond workforce shortages, showing how the ...
DeLorean AI is targeting Chronic Kidney Disease by using precision predictive analytics to spot renal decline years before ...
Patients on hemodialysis, either in a center or at home, who used a specialized kidney pharmacy program had lower mortality ...
With more than 250 peer-reviewed papers published in several high-impact journals, Katalin Susztak, MD, PhD, has opened the ...
Akebia Therapeutics has decided not to initiate a clinical trial assessing vadadustat in patients with late-stage CKD not on dialysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results